Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Down 10.0% in November

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 508,200 shares, a decrease of 10.0% from the November 15th total of 564,600 shares. Approximately 11.9% of the company’s stock are short sold. Based on an average daily volume of 287,400 shares, the days-to-cover ratio is currently 1.8 days.

Intelligent Bio Solutions Stock Performance

NASDAQ:INBS opened at $1.50 on Tuesday. The firm has a 50-day simple moving average of $1.55 and a two-hundred day simple moving average of $1.63. Intelligent Bio Solutions has a fifty-two week low of $1.00 and a fifty-two week high of $11.70.

Intelligent Bio Solutions (NASDAQ:INBS) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) earnings per share for the quarter, missing the consensus estimate of ($0.53) by ($0.17). The company had revenue of $872.29 million for the quarter. Intelligent Bio Solutions had a negative net margin of 288.35% and a negative return on equity of 147.50%. On average, research analysts forecast that Intelligent Bio Solutions will post -1.25 earnings per share for the current fiscal year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.